Unfavorable Intermediate-risk Prostate Cancer
📧 Sign up to get email alerts when something new happens for Unfavorable Intermediate-risk Prostate Cancer.
Sign up free-
CLINICAL_TRIALS research · 2026-01-21Clinical Trial Update: Addition of Focal Boost to Primary Radiotherapy for Prostate Cancer in 12 or 20 Fractions [NA]
A clinical trial update shows that focal boost to primary radiotherapy for prostate cancer in 12 or 20 fractions is being investigated and t…